Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of David Concannon
 

David Concannon

 
Partner - Andrews Kurth LLP
 
David Concannon Email :
Please login
 
Company Name : Andrews Kurth LLP
 
Company Website : www.akllp.com
 
Company Address : 111 Congress Ave.
Ste. 1700, Austin, TX,
United States,
 
David Concannon Profile :
Partner - Andrews Kurth LLP
 
David Concannon Biography :

David's practice includes significant experience in general corporate and securities work with an emphasis on capital markets, merger and acquisition and venture capital transactions for technology companies; specifically formation and organization of start-ups, venture capital financings, public offerings of debt and equity securities, public and private mergers and acquisitions, restructurings, joint ventures and other corporate partnering arrangements, and counseling regarding, among others, general corporate matters, financings, mergers and acquisitions and securities law compliance for public and private corporations.

REPRESENTATIVE EXPERIENCE

Representative venture capital transactions include:

Counsel to Monitor110, Inc. in connection with $11 million Series C Preferred Stock financing

Counsel to United BioFuels Europe Cayman Holdings Ltd. in connection with €10 million Series C Preferred Stock financing

Counsel to Monitor110, Inc. in connection with $5 million Series B Preferred Stock financing

Counsel to United BioFuels Europe Cayman Holdings Ltd. in connection with $25 million Series B Preferred Stock financing

Counsel to UR Power GmbH in connection with €12.5 million Series C Preferred Stock financing

Counsel to George Soros in connection with $14 million Series A Preferred Stock financing of LabNow, Inc.

Counsel to Perseus-Soros BioPharmaceutical Fund, L.P. in connection with $48 million Series C Preferred Stock financing of Avera Pharmaceuticals, Inc.

Counsel to Perseus-Soros BioPharmaceutical Fund, L.P. in connection with $8 million Series B Preferred Stock financing of ArgiNOx Pharmaceuticals, Inc.

Counsel to Currenex, Inc. in connection with $3.75 million Series B-1 Preferred Stock financing

Counsel to Perseus-Soros BioPharmaceutical Fund, L.P. in connection with $37 million Series A Preferred Stock financing of CardioKine, Inc.

Counsel to TL Ventures and affiliates in connection with $15 million Series B Preferred Stock financing of Circadiant Systems, Inc.

Representative capital markets transactions include:

Counsel to Hydrogenics Corporation in connection with $84 million initial public offering of common shares

Counsel to Merrill Lynch, Pierce, Fenner & Smith Incorporated as underwriter in connection with $90 million initial public offering of common stock of Adolor Corporation

Counsel to Merrill Lynch, Pierce, Fenner & Smith Incorporated as underwriter in connection with $240 million initial public offering of class A common shares of Iridium World Communications Ltd.

Counsel to RightChoice Managed Care, Inc. in connection with $35 million initial public offering of common stock

Counsel to Vanguard Airlines, Inc. in connection with initial public offering of common stock

Counsel to American Safety Razor Company in connection with $60 million initial public offering of common stock

Merger and Acquisition Transactions:

Counsel to Currenex, Inc. in connection with its $564 million cash sale to State Street Corporation

Counsel to Agricapital GmbH in connection with spinoff of its vegetable-oil fueled power plant division

Counsel to Agricapital GmbH in connection with spinoff of its Hungarian ethanol-biogas power plant division

U.S. Counsel to Apax Partners in connection with £173 million asset purchase of Regent Biogel and Hibi businesses from SSL International plc.

Counsel to PSINet Consulting Solutions Holdings, Inc. in connection with its sale of the assets of its Enterprise Solutions Division

Counsel to BevAccess.com, Inc. in connection with acquisition of The Beverage Media Group, Ltd.

Counsel to Axsys Technologies, Inc. in connection with divestiture of Beau Interconnect division

Counsel to Forstmann Little & Co. in connection with $2.4 billion cash sale (stock) of Ziff-Davis Holdings Corp. to Softbank Corporation

Counsel to Columbia/HCA Healthcare Corporation in connection with the $1.4 billion cash acquisition (tender offer) of Value Health, Inc.

Counsel to Forstmann Little & Co. in connection with $1.4 billion cash acquisition (tender offer) of Community Health Systems, Inc.

Counsel to Guardian Royal Exchange Assurance Ltd. in connection with $1.2 billion cash acquisition of ING US P&C Corporation

Counsel to AEA Investors Inc. in connection with $70.0 million stock purchase of Manchester Tank & Equipment Co.

ARTICLES / PUBLICATIONS

Author - Option Exchange Programs: Practical Considerations in Implementing Programs After the SEC’s Exemptive Order, M&A Lawyer (May 2001)

BRIEFINGS, SEMINARS & SPEECHES

Speaker - Representing High-Tech Clients, Harvard Journal of Law and Technology (September 2001)

PROFESSIONAL / CIVIC AFFILIATIONS

Member

New York State Bar Association

New York New Media Association

American Bar Association



 
David Concannon Colleagues :
Name Title Email

Georgia Adams

Please login

Christopher Allen

Sr. Attorney Please login

Brian Amis

Counsel Please login

Brannon Andrews

Assoc. Attorney Please login

Mark Arnold

Assoc. Attorney Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.